Previous genetic studies have shown that heterozygous knockout of SKP1, CUL1, RBX1 and FBXO7 induces CIN [9,10,11], an enabling hallmark of cancer [70] frequently associated with cellular transformation, drug resistance, metastasis and poor patient prognosis in many cancer types [71,72,73,74,75]. Here, RBX1 is linked to cancer.